GENYLDRA Trademark

Trademark Overview

On Thursday, February 4, 2016, a trademark application was filed for GENYLDRA with the United States Patent and Trademark Office. The USPTO has given the GENYLDRA trademark a serial number of 86897268. The federal status of this trademark filing is REGISTERED as of Tuesday, May 22, 2018. This trademark is owned by Sun Pharma Global FZE. The GENYLDRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders; Pharmaceutical preparations for the treatment of cancer
genyldra

General Information

Serial Number86897268
Word MarkGENYLDRA
Filing DateThursday, February 4, 2016
Status700 - REGISTERED
Status DateTuesday, May 22, 2018
Registration Number5472436
Registration DateTuesday, May 22, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders; Pharmaceutical preparations for the treatment of cancer
Translation of Words in MarkThe wording "GENYLDRA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 9, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSUN PHARMACEUTICAL INDUSTRIES LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressVADODARA, GUJARAT 390012
IN
Party NameSun Pharma Global FZE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDubai
AE

Trademark Events

Event DateEvent Description
Monday, May 22, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 29, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, January 26, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, January 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 23, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, January 23, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 23, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, January 23, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, January 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 22, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 20, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, July 20, 2017INQUIRY TO SUSPENSION E-MAILED
Thursday, July 20, 2017SUSPENSION INQUIRY WRITTEN
Thursday, July 20, 2017SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, January 18, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 18, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, January 18, 2017SUSPENSION LETTER WRITTEN
Wednesday, January 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 18, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 9, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 2, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 2, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, December 2, 2016SUSPENSION INQUIRY WRITTEN
Tuesday, November 29, 2016SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, November 18, 2016ASSIGNED TO LIE
Monday, May 16, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 16, 2016LETTER OF SUSPENSION E-MAILED
Monday, May 16, 2016SUSPENSION LETTER WRITTEN
Thursday, May 12, 2016ASSIGNED TO EXAMINER
Wednesday, March 23, 2016TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, March 23, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, February 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 8, 2016NEW APPLICATION ENTERED

Related Keywords

genyldra pharmaceutical disorders treatment preparations system diseases mediated inflammatory cancer immunologically